Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients

Qing Lei(Huazhong University of Science and Technology), Xionglin Fan(Huazhong University of Science and Technology), Zhuqing Ouyang(Huazhong University of Science and Technology), Jun‐biao Xue(Shanghai Jiao Tong University), Yun-xiao Zheng(Shanghai Jiao Tong University), Huan Qi(Qingdao Institute of Bioenergy and Bioprocess Technology), Zhaowei Xu(Shanghai Jiao Tong University), Caizheng Yu(Huazhong University of Science and Technology), Meian He(Ministry of Ecology and Environment), Sheng‐ce Tao(Shanghai Jiao Tong University), Xuening Wang(Shanxi Medical University), He‐wei Jiang(Shanghai Jiao Tong University), Ziyong Sun(Tongji Hospital), Yandi Zhang(Liaoning Normal University), Hong Chen(Shanghai Jiao Tong University), Yang Li(Shanghai Jiao Tong University), Bo Zhang(Tongji Hospital), Hainan Zhang(Shanghai Jiao Tong University), Feng Wang(Shanghai Jiao Tong University), Xiaosong Lin(Huazhong University of Science and Technology), Hongyan Hou(Tongji Hospital), Dan‐yun Lai(Shanghai Jiao Tong University), Jo‐Lewis Banga Ndzouboukou(Huazhong University of Science and Technology), Shujuan Guo(Shanghai Jiao Tong University), Zongjie Yao(Huazhong University of Science and Technology)
Journal of Advanced Research
November 26, 2021
Cited by 13


Related Papers